Logo for Cerus Corporation

Cerus Investor Relations Material

Latest events

Logo for Cerus Corporation

Q1 2025

Cerus
Logo for Cerus

Q1 2025

1 May, 2025
Logo for Cerus

Corporate Presentation

25 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Cerus Corporation

Access all reports
Cerus Corporation develops and markets blood safety technologies intended to reduce the risk of transfusion-transmitted infections. Its INTERCEPT platform is used to treat blood components such as platelets and plasma. The company serves blood centers, hospitals, and transfusion services. The company is headquartered in Concord, California, and its shares are listed on the NASDAQ.